538 related articles for article (PubMed ID: 34491806)
21. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
[TBL] [Abstract][Full Text] [Related]
22. Bacterial Coinfections in Coronavirus Disease 2019.
Westblade LF; Simon MS; Satlin MJ
Trends Microbiol; 2021 Oct; 29(10):930-941. PubMed ID: 33934980
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic-Resistant Infections Among Inpatients with Coronavirus Disease 2019 (COVID-19) in US Hospitals.
Baggs J; Rose AN; McCarthy NL; Wolford H; Srinivasan A; Jernigan JA; Reddy SC
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S294-S297. PubMed ID: 35779273
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of COVID-19 patients with bacterial coinfection admitted to the hospital from the emergency department in a large regional healthcare system.
Lardaro T; Wang AZ; Bucca A; Croft A; Glober N; Holt DB; Musey PI; Peterson KD; Trigonis RA; Schaffer JT; Hunter BR
J Med Virol; 2021 May; 93(5):2883-2889. PubMed ID: 33448423
[TBL] [Abstract][Full Text] [Related]
25. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
[TBL] [Abstract][Full Text] [Related]
26. Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19: A Multicenter Observational Cohort Study.
Hessels LM; Speksnijder E; Paternotte N; van Huisstede A; Thijs W; Scheer M; van der Steen-Dieperink M; Knarren L; van Den Bergh JP; Winckers K; Henry R; Simsek S; Boersma WG;
Chest; 2023 Sep; 164(3):596-605. PubMed ID: 37116748
[TBL] [Abstract][Full Text] [Related]
27. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
[TBL] [Abstract][Full Text] [Related]
28. Increased rates of secondary bacterial infections, including
DeVoe C; Segal MR; Wang L; Stanley K; Madera S; Fan J; Schouest J; Graham-Ojo R; Nichols A; Prasad PA; Ghale R; Love C; Abe-Jones Y; Kangelaris KN; Patterson SL; Yokoe DS; Langelier CR
Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1416-1423. PubMed ID: 34486503
[TBL] [Abstract][Full Text] [Related]
29. Impact of Sex and Metabolic Comorbidities on Coronavirus Disease 2019 (COVID-19) Mortality Risk Across Age Groups: 66 646 Inpatients Across 613 U.S. Hospitals.
Goodman KE; Magder LS; Baghdadi JD; Pineles L; Levine AR; Perencevich EN; Harris AD
Clin Infect Dis; 2021 Dec; 73(11):e4113-e4123. PubMed ID: 33337474
[TBL] [Abstract][Full Text] [Related]
30. Coinfections among hospitalized patients with covid-19 in the first pandemic wave.
Zamora-Cintas MI; López DJ; Blanco AC; Rodriguez TM; Segarra JM; Novales JM; Ferriol MFR; Maestre MM; Sacristán MS
Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115416. PubMed ID: 34391076
[TBL] [Abstract][Full Text] [Related]
31. Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.
Nakagawara K; Kamata H; Chubachi S; Namkoong H; Tanaka H; Lee H; Otake S; Fukushima T; Kusumoto T; Morita A; Azekawa S; Watase M; Asakura T; Masaki K; Ishii M; Endo A; Koike R; Ishikura H; Takata T; Matsushita Y; Harada N; Kokutou H; Yoshiyama T; Kataoka K; Mutoh Y; Miyawaki M; Ueda S; Ono H; Ono T; Shoko T; Muranaka H; Kawamura K; Mori N; Mochimaru T; Fukui M; Chihara Y; Nagasaki Y; Okamoto M; Amishima M; Odani T; Tani M; Nishi K; Shirai Y; Edahiro R; Ando A; Hashimoto N; Ogura S; Kitagawa Y; Kita T; Kagaya T; Kimura Y; Miyazawa N; Tsuchida T; Fujitani S; Murakami K; Sano H; Sato Y; Tanino Y; Otsuki R; Mashimo S; Kuramochi M; Hosoda Y; Hasegawa Y; Ueda T; Takaku Y; Ishiguro T; Fujiwara A; Kuwahara N; Kitamura H; Hagiwara E; Nakamori Y; Saito F; Kono Y; Abe S; Ishii T; Ohba T; Kusaka Y; Watanabe H; Masuda M; Watanabe H; Kimizuka Y; Kawana A; Kasamatsu Y; Hashimoto S; Okada Y; Takano T; Katayama K; Ai M; Kumanogoh A; Sato T; Tokunaga K; Imoto S; Kitagawa Y; Kimura A; Miyano S; Hasegawa N; Ogawa S; Kanai T; Fukunaga K;
BMC Pulm Med; 2023 Apr; 23(1):146. PubMed ID: 37101265
[TBL] [Abstract][Full Text] [Related]
32. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus.
Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Nauclér P
BMC Infect Dis; 2022 Jan; 22(1):108. PubMed ID: 35100984
[TBL] [Abstract][Full Text] [Related]
33. Risk factors, outcomes, and epidemiological and etiological study of hospitalized COVID-19 patients with bacterial co-infection and secondary infections.
Duan Y; Wang J; Wang S; Zhang R; Hu J; Li W; Chen B
Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):577-586. PubMed ID: 38246947
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
[TBL] [Abstract][Full Text] [Related]
35. Bacterial infections in patients with COVID-19: the impact of procalcitonin testing on antibiotics prescription in the real world.
Lui GC; Cheung CS; Yip TC; Lai MS; Li TC; Wong GL
BMC Infect Dis; 2024 Jan; 24(1):106. PubMed ID: 38243171
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.
Langford BJ; So M; Raybardhan S; Leung V; Soucy JR; Westwood D; Daneman N; MacFadden DR
Clin Microbiol Infect; 2021 Apr; 27(4):520-531. PubMed ID: 33418017
[TBL] [Abstract][Full Text] [Related]
37. Bacterial infections and antibiotic utilization varies by coronavirus disease 19 (COVID-19) severity in hospitalized cancer patients: Analysis from the first phase of the pandemic.
Maki KR; Steiger SN; Su Y; Boumiza A; Tan CA; Kerpelev M; Seo SK; Cohen N
Infect Control Hosp Epidemiol; 2023 Mar; 44(3):413-419. PubMed ID: 35616016
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic Use and Associated Risk Factors for Antibiotic Prescribing in COVID-19 Hospitalized Patients.
Martin AJ; Shulder S; Dobrzynski D; Quartuccio K; Pillinger KE
J Pharm Pract; 2023 Apr; 36(2):256-263. PubMed ID: 34291681
[TBL] [Abstract][Full Text] [Related]
39. Clinical and virological impact of single and dual infections with influenza A (H1N1) and SARS-CoV-2 in adult inpatients.
Zheng J; Chen F; Wu K; Wang J; Li F; Huang S; Lu J; Huang J; Liu H; Zhou R; Huang Z; Meng B; Yuan Z; Wu X
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009997. PubMed ID: 34843492
[TBL] [Abstract][Full Text] [Related]
40. Community-Onset Bacterial Coinfection in Children Critically Ill With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Moffitt KL; Nakamura MM; Young CC; Newhams MM; Halasa NB; Reed JN; Fitzgerald JC; Spinella PC; Soma VL; Walker TC; Loftis LL; Maddux AB; Kong M; Rowan CM; Hobbs CV; Schuster JE; Riggs BJ; McLaughlin GE; Michelson KN; Hall MW; Babbitt CJ; Cvijanovich NZ; Zinter MS; Maamari M; Schwarz AJ; Singh AR; Flori HR; Gertz SJ; Staat MA; Giuliano JS; Hymes SR; Clouser KN; McGuire J; Carroll CL; Thomas NJ; Levy ER; Randolph AG
Open Forum Infect Dis; 2023 Mar; 10(3):ofad122. PubMed ID: 36968962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
